Total Payments
$2,956
2023 Payments
$151.73
Companies
31
Transactions
173
Medicare Patients
5,241
Medicare Billing
$548,594
Payment Breakdown by Category
Food & Beverage$2,823 (95.5%)
Education$133.08 (4.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,823 | 167 | 95.5% |
| Education | $133.08 | 6 | 4.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $494.42 | 35 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $331.51 | 17 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $317.57 | 22 | $0 (2022) |
| PORTOLA PHARMACEUTICALS, INC. | $254.04 | 2 | $0 (2019) |
| Genentech USA, Inc. | $195.02 | 11 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $175.30 | 12 | $0 (2018) |
| La Jolla Pharmaceutical Company | $122.39 | 1 | $0 (2023) |
| Mylan Specialty L.P. | $121.50 | 8 | $0 (2022) |
| PFIZER INC. | $99.68 | 7 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $96.52 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $151.73 | 3 | La Jolla Pharmaceutical Company ($122.39) |
| 2022 | $390.17 | 24 | GlaxoSmithKline, LLC. ($73.28) |
| 2021 | $354.35 | 27 | Mylan Specialty L.P. ($62.02) |
| 2020 | $191.40 | 14 | GlaxoSmithKline, LLC. ($69.27) |
| 2019 | $543.71 | 21 | PORTOLA PHARMACEUTICALS, INC. ($254.04) |
| 2018 | $464.83 | 34 | AstraZeneca Pharmaceuticals LP ($96.06) |
| 2017 | $860.13 | 50 | Boehringer Ingelheim Pharmaceuticals, Inc. ($161.03) |
All Payment Transactions
173 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/28/2023 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $122.39 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 01/12/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: RESPIRATORY | ||||||
| 01/11/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/19/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: RESPIRATORY | ||||||
| 12/07/2022 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: NEUROLOGY | ||||||
| 12/06/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2022 | Covis Pharma GmBH | ALVESCO (Drug), TUDORZA PRESSAIR | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Respiratory | ||||||
| 11/02/2022 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Pulmonology | ||||||
| 11/02/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: IMMUNOLOGY | ||||||
| 10/26/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Rare Disease | ||||||
| 10/24/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: RESPIRATORY | ||||||
| 09/23/2022 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Pulmonology | ||||||
| 08/15/2022 | Covis Pharma GmBH | ALVESCO (Drug), TUDORZA PRESSAIR | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Respiratory | ||||||
| 07/06/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: IMMUNOLOGY | ||||||
| 06/20/2022 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $59.98 | General |
| Category: PULMONOLOGY | ||||||
| 06/09/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: RESPIRATORY | ||||||
| 05/12/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: VACCINES | ||||||
| 05/04/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: RESPIRATORY | ||||||
| 04/21/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Respiratory | ||||||
| 04/08/2022 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Respiratory | ||||||
| 03/28/2022 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: PAH | ||||||
| 03/23/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/16/2022 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Respiratory | ||||||
| 03/09/2022 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: Medical Device | ||||||
| 02/16/2022 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,256 | 1,545 | $458,748 | $122,347 |
| 2022 | 21 | 1,380 | 1,756 | $637,147 | $158,951 |
| 2021 | 18 | 1,281 | 1,615 | $514,337 | $132,500 |
| 2020 | 18 | 1,324 | 1,634 | $539,649 | $134,796 |
Total Patients
5,241
Total Services
6,550
Medicare Billing
$548,594
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 138 | 202 | $56,358 | $21,335 | 37.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 196 | 268 | $48,508 | $19,844 | 40.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 84 | 97 | $86,815 | $17,574 | 20.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 126 | 192 | $49,344 | $13,030 | 26.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 89 | 113 | $41,584 | $11,565 | 27.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 61 | 63 | $30,555 | $6,716 | 22.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 138 | 158 | $35,866 | $5,513 | 15.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 97 | 105 | $22,155 | $5,393 | 24.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 26 | 27 | $19,359 | $4,075 | 21.0% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 95 | 103 | $16,995 | $4,063 | 23.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $13,662 | $3,037 | 22.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 16 | $6,304 | $2,317 | 36.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 20 | 21 | $1,470 | $1,441 | 98.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 30 | 31 | $3,720 | $1,404 | 37.7% |
| 32555 | Aspiration of fluid from chest cavity using imaging guidance | Facility | 2023 | 13 | 14 | $5,628 | $1,322 | 23.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 39 | 42 | $7,560 | $1,216 | 16.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $4,334 | $886.53 | 20.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 21 | 22 | $550.00 | $539.00 | 98.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 11 | $1,529 | $476.85 | 31.2% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 12 | 12 | $5,808 | $476.20 | 8.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 11 | 14 | $644.00 | $123.90 | 19.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 175 | 257 | $230,015 | $47,421 | 20.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 230 | 327 | $120,336 | $28,452 | 23.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 174 | 250 | $45,250 | $19,176 | 42.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 108 | 162 | $45,198 | $18,260 | 40.4% |
About Dr. Steven Jacoby, MD
Dr. Steven Jacoby, MD is a Critical Care Medicine healthcare provider based in Midland Park, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1619977667.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Jacoby, MD has received a total of $2,956 in payments from pharmaceutical and medical device companies, with $151.73 received in 2023. These payments were reported across 173 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($2,823).
As a Medicare-enrolled provider, Jacoby has provided services to 5,241 Medicare beneficiaries, totaling 6,550 services with total Medicare billing of $548,594. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Midland Park, NJ
- Active Since 07/29/2005
- Last Updated 09/11/2025
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1619977667
Products in Payments
- ANDEXXA (Biological) $269.04
- SYMBICORT (Drug) $208.40
- NUCALA (Biological) $196.01
- GIAPREZA (Drug) $122.39
- Yupelri (Drug) $106.68
- OFEV (Drug) $106.02
- Esbriet (Biological) $101.39
- Xolair (Biological) $93.63
- BROVANA (Drug) $91.96
- Arikayce (Drug) $88.40
- BREO (Drug) $86.43
- ANORO ELLIPTA (Drug) $71.03
- STIOLTO RESPIMAT (Drug) $70.85
- CHANTIX (Drug) $69.70
- TRELEGY ELLIPTA (Drug) $66.06
- CHARTIS CATHETER (Device) $59.98
- UTIBRON (Drug) $58.26
- ANORO (Drug) $52.66
- DUPIXENT (Biological) $49.95
- QVAR (Drug) $46.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.